B-CELL LYMPHOMA A051701

Study #A051701

Randomized Phase II/III Study of Ventoclax (ABT 199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double-Expressing Lymphomas

Back To Clinical Trials